POLYMYXIN B SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Polymyxin B Sulfate patents expire, and what generic alternatives are available?
Polymyxin B Sulfate is a drug marketed by Adrastea Pharma, Eugia Pharma, Fresenius Kabi Usa, Gland, Hikma, Rising, Xellia Pharms Aps, and Paddock Llc. and is included in eight NDAs.
The generic ingredient in POLYMYXIN B SULFATE is polymyxin b sulfate. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Polymyxin B Sulfate
A generic version of POLYMYXIN B SULFATE was approved as polymyxin b sulfate by ADRASTEA PHARMA on September 30th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POLYMYXIN B SULFATE?
- What are the global sales for POLYMYXIN B SULFATE?
- What is Average Wholesale Price for POLYMYXIN B SULFATE?
Summary for POLYMYXIN B SULFATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Clinical Trials: | 6 |
| DailyMed Link: | POLYMYXIN B SULFATE at DailyMed |
Recent Clinical Trials for POLYMYXIN B SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Madonna Magdy Fahmy | Early Phase 1 |
| Bascom Palmer Eye Institute | N/A |
| University of Miami | N/A |
Pharmacology for POLYMYXIN B SULFATE
| Drug Class | Polymyxin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for POLYMYXIN B SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for POLYMYXIN B SULFATE
US Patents and Regulatory Information for POLYMYXIN B SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adrastea Pharma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 063000-001 | Sep 30, 1994 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Xellia Pharms Aps | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 202766-001 | Jan 15, 2014 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 207322-001 | Apr 14, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Paddock Llc | POLYMYXIN B SULFATE | polymyxin b sulfate | POWDER;FOR RX COMPOUNDING | 062455-001 | Jul 27, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Eugia Pharma | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 206589-001 | Apr 4, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 065372-001 | Jan 10, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 090110-001 | Jun 29, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
